Nichts verpassen und Zeit sparen!
Es wurden passende Jobs für dich gefunden:
Chemiker*Deine E-Mail Adresse wird nicht weitergegeben. Mit Absenden akzeptierst du die AGB und Datenschutzbestimmungen.
Heidelberg, Baden-Württemberg
„Research for a life without cancer“ is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully. Every contribution counts - whether in research, administration or infrastructure. This is what makes our daily work so meaningful and exciting.
The Division of Scientific Board is seeking as soon as possible a
The German Cancer Research Center (DKFZ) welcomes applications for a tenured position as Division Head in Pediatric Cancer Drug Discovery. This position offers a unique opportunity to lead a pioneering research program aimed at developing innovative therapies for childhood cancers, which present distinct biological challenges and limited commercial incentives due to small patient populations and thus market sizes. Academic drug discovery thereby is key to address this unmet medical need and advance treatment options for children with cancer.
The DKFZ division will be embedded within the Hopp Children’s Cancer Center Heidelberg (KiTZ, https://www.kitz-heidelberg.de/en/ ), the leading pediatric oncology research center in Germany that integrates cutting-edge basic, translational, and clinical research and will be part of one of the DKFZ’s research programs.
The new division will conduct cutting-edge, translational drug discovery research, with potential focus areas including:
The successful candidate will benefit from access to the state-of-the-art infrastructure of the DKFZ, including core facilities and research platforms as well as our non-for-profit spin-off pediatric drug testing platform www.itccp4.com supporting drug discovery research as well as a co-affiliation with Heidelberg University and Heidelberg University Hospital, fostering interdisciplinary collaborations. The division will be associated with the German Cancer Consortium (DKTK, https://dktk.dkfz.de/en) and with the National Center for Tumor Diseases (NCT, https://nct.dkfz.de/), which have wide expertise in drug discovery, drug development, and translational research. Access to pediatric oncology, genomics, drug testing and modeling experts at KiTZ across all major entities, will foster creating a very collaborative and dynamic research environment. Furthermore, translational pipelines including IIT development and coordination within the KiTZ are existing and accessible (https://www.kitz-heidelberg.de/en/clinical-studies/kitz-clinical-trial-unit). An existing bioinformatics group (https://www.kitz-heidelberg.de/en/research/research-groups/cns-/-brain-tumors/group-clinical-bioinformatics) will be embedded within the new division, providing computational expertise and support for AI-based drug discovery efforts.
You can look forward to:
Pediatric cancers are biologically distinct from adult cancers, requiring innovative therapeutic strategies. Given the small market size and limited commercial incentives, academic-driven research is essential to develop effective treatments. At KiTZ and DKFZ, you will work alongside world-renowned experts in clinical, preclinical, and fundamental scientific research, contributing to a dynamic and collaborative environment. Your work will be instrumental in uniting diverse scientific disciplines to advance pediatric cancer treatment through groundbreaking discoveries, translational research and clinical trials.
Interested candidates should submit the following documents:
Join us at DKFZ and KiTZ to drive innovation in pediatric cancer drug discovery and make a lasting impact on children’s lives.
Then become part of the DKFZ and join us in contributing to a life without cancer!
We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, personal identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.
Notice: We are subject to the regulations of the Infection Protection Act (IfSG). Therefore, all our employees must provide proof of immunity against measles.
€ 83.164
Im Neuenheimer Feld 280
69120 Heidelberg
Baden-Württemberg
Deutschland